Castill Health Announces Plans for Philippines Digital Healthcare Launch, Supported by Craig Astill and Caason Group 
PDF to PPT Converter From Presentations.AI Turns PDFs Into Editable PowerPoint Slide Decks With AI, Keeping Charts, Tables and Images Intact, as a Free-to-Try Gamma and Beautiful.ai Alternative 
Hong Kong Autumn Electronics Fair and electronicAsia attract over 61,000 buyers for sourcing, business opportunities Checkpoint Capital Names Jack Stimac as President and Head of Financial Strategies
AUSTIN, Texas–(BUSINESS WIRE)–#FDIC—Checkpoint Capital, LLC, a FinTech capital markets specialist firm supporting depository institutions, has…
Generate Capital Announces Promotion and Hiring of Managing Directors
SAN FRANCISCO–(BUSINESS WIRE)–Generate Capital, PBC, a leading sustainable infrastructure investment and operating platform, today announced…
Great Place to Work® Names DexCare One of the Fortune Best Small Workplaces™ in 2022, Ranking #63
Employees affirm positive workplace fostered by DexCare, with 100% of respondents saying they look forward…
Toshiba’s Retail Division Opens Innovation & Incubation Hub in Frisco, Texas
Expanded footprint accelerates the company’s growth strategy around ELERA innovation and cloud development while broadening…
Blackline Safety Provides Business Update, Positioning for Improved Financial Strength
Hardware and service pricing increase coupled with cost reductions to improve Blackline’s cash generating capabilities…
Heartdub: How Innovative Technology Demonstrates Runway’s New Rhythm
Virtual Musician “K” performing on SHFW AW2022 SEATTLE–(BUSINESS WIRE)–#digitalfashion–After the delay caused by Shanghai’s two-month-long…
EMQ Joins the Oracle PartnerNetwork (OPN), Enhancing Cloud-based IoT Connectivity Solutions for Global Clients
EMQ Technologies, a global provider of open-source IoT data infrastructure solutions, today announced that it…
EyeC Launches Proofiler Version 4.2 And Introduces New RS Scanner System
Hamburg, August 8, 2022. EyeC, the worldwide expert for vision systems for print image inspection…
Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update
SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Kala Pharmaceuticals to Report Second Quarter 2022 Financial Results and Host Conference Call
ARLINGTON, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical…
SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
The trial’s objectives are to evaluate the safety, tolerability and efficacy of SciSparc’s SCI-210 in…
Longeveron to Announce Second Quarter 2022 Financial Results on August 12, 2022
Live conference call on Friday, August 12 at 8:30 a.m. EST MIAMI, Aug. 08, 2022…
POINT Biopharma to Host Investor Education Event, “Understanding the PNT2002 Phase 3 SPLASH Trial Control Arm”, on August 18, 2022
The event will prepare investors for the release of SPLASH’s lead-in cohort efficacy data later…
Celsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022
LAWRENCEVILLE, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
Salarius Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Multiple development and data milestones expected from seclidemstat and SP-3164 programs in 2H22 Conference call…
Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development
Extends Rani’s projected cash runway into mid-2024 SAN JOSE, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE)…
RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition
Glen Rock, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
TRACON Pharmaceuticals Announces Submission of IND Application for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab
SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
-CLIMB-111 and CLIMB-121 fully enrolled; completed regulatory discussions for exagamglogene autotemcel (exa-cel), formerly known as…
Vaxart Appoints W. Mark Watson to its Board of Directors
Non-executive director to bring extensive life science industry and finance experience SOUTH SAN FRANCISCO, Calif.,…